Welcome : Guest

Amphastar Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Amphastar Pharmaceuticals, Inc., which is principally involved in Specialty Pharmaceuticals Business. Illustrated with 67 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-63726
Price: $3350
Company Type: Public
Pages: 72
Date: November 2016
Market Data Tables: 67

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Amphastar Pharmaceutical, Inc.’s Sales by Customers Worldwide (2014-2015) in Percentage for Allergan Plc, AmerisourceBergen, Cardinal Health, MannKind Corporation, McKesson, and Others......5
Table 2: Amphastar Pharmaceutical, Inc.’s Sales by Product Segment Worldwide (2014-2015) in Percentage for Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients (API)......6
Table 3: Amphastar Pharmaceutical, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for U.S., and France......7
Table 4: Amphastar Pharmaceutical, Inc.’s Sales by Product Segment Worldwide (2014) in Percentage for Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API)......8
Table 5: Amphastar Pharmaceutical, Inc.’s Sales by Geographic Region Worldwide (2014) in Percentage for U.S. and France......9
Active Pharmaceutical Ingredients (API)......11
Table 6: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......11
Table 7: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others......12
Table 8: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2015) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......13
Table 9: Pharmaceuticals Services and Active Ingredients (PSAI) Segment Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America and Rest of the World......14
Table 10: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......15
Asthma Drugs......16
Table 11: Asthma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......16
Table 12: No. of Asthma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......17
Table 13: Asthma Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Advair Diskus, Combivent, Proair HFA, Singulair, Spiriva HandiHaler, Symbicort, and Others......18
Anti-Clotting......19
Table 14: Anti-Clotting Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Enoxaparin, Fondaparinux, Heparin and Xa inhibitors......19
Non-Insulin Anti-Diabetic Drugs......20
Table 15: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......20
Insulin......21
Table 16: Insulin Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......21
Table 17: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......22
Table 18: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......23
Table 19: Insulin Market by Generation in China (2015) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......24
Table 20: Insulin Market by Product Type in the US (2015) - Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......25
Anticoagulant......26
Table 21: Anticoagulant Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Heparin, Low-Molecular-Weight Heparin (LMWH), Novel Oral Anticoagulants, Warfarin, and Other Injectable Anticoagulants......26
Table 22: Anticoagulation Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Direct Thrombin Inhibitors (DTI), Low-Molecular-Weight Heparin (LMWH), Unfractionated Heparin (UFH), Vitamin K Antagonists (VKA) and Others......27
Low-Molecular-Weight Heparin......28
Table 23: Low-Molecular-Weight Heparin Market by Product in China (2015) - Percentage Share Breakdown by Value for Clexane (Sanofi-Aventis), Fluxum (Alfa Wassermann), Fraxiparine (GSK), Wanmaishu (CS Bio) and Others......28
Buprenorphine and Naloxone Drugs......29
Table 24: Buprenorphine and Naloxone Drugs Market by Payers Worldwide (2015) - Percentage Share Breakdown by Value for Assistance Programmes, Commercial, Medicaid and Others......29
Morphine......30
Table 25: Long-Acting Morphine Market by Category in the US (2015) - Percentage Share Breakdown by Value for Branded and Generics......30
Table 26: Narcotic Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value Sales for Butorphanol, Daphine Giraldii Nitsche, Dihydrocodeine/Paracetamol and dihydrocodeine, Fentanyl, Morphine, Oxycodone Acetaminophen, Tramadol, and Others......31
Table 27: Narcotic Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Morphine, Oxycodone, Tramadol and Others......32
Anti-Clotting......33
Table 28: Market Shares of Leading Anti-Clotting Brands in the US (2015) - Percentage Market Share Breakdown by Value for Arixtra, Enoxaparin, Fonda. - APO, Heparin, Lovenox, and Xarelto......33
Insulin......34
Table 29: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......34
Table 30: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......35
Table 31: Market Shares of Leading Fast & Intermediate Type Insulin Producers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company, Novo Nordisk, Sanofi S.A. and Others......36
Table 32: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......37
Table 33: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......38
Table 34: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......39
Table 35: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......40
Table 36: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......41
Table 37: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......42
Table 38: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......43
Second-Generation Insulin......44
Table 39: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co., Ltd.......44
Third-Generation Insulin......45
Table 40: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......45
Human Insulin......46
Table 41: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......46
Porcine Insulin......47
Table 42: Animal Feed Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Aqua, Porcine, Poultry, Ruminant, and Others......47
Injectable Drugs......48
Table 43: Market Shares of Leading Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co. KGaA, Hospira, Inc., Novartis AG, Pfizer, Inc., West-Ward Pharmaceuticals Corporation, and Others......48
Table 44: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......49
Table 45: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......50
Table 46: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......51
Table 47: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......52
Table 48: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......53
Table 49: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......54
Table 50: Market Shares of Leading Injectable Miotics Manufacturers in the US (2015) - Percentage Breakdown by Value for Alcon Incorporated, and Novartis International AG......55
Generic Pharmaceuticals......56
Table 51: Global IV Generics Drug Market by Value Sales (2015) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......56
Table 52: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Others......57
Table 53: Market Shares of Leading Generics Manufacturers in Australia (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Aspen Pharmaceutical Holdings Ltd., Mylan, Inc., Sandoz and Others......58
Table 54: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......59
Table 55: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......60
Table 56: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......61
Table 57: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......62
Table 58: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Volume for Actavis plc, Mylan N.V., Sandoz, Teva Pharmaceutical Industries Ltd. and Others......63
Table 59: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Dr. Reddy’s Laboratories Ltd. and GlaxoSmithKline......64
Table 60: Market Shares of Leading Derma Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis plc, Perrigo Company plc, Sandoz, Taro Pharmaceutical Industries Ltd. and Others......65
Table 61: Market Shares of Leading Non-Branded Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis, Mylan N.V., Teva Pharmaceutical Industries Ltd. and Others......66
Table 62: Market Shares of Leading Generic Injectable Drug Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., Fresenius, Hospira, Inc., Novartis (Sandoz), and Others......67
IV Generic Drugs......68
Table 63: Market Shares of Leading IV Generic Drugs Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Baxter International, Inc., Fresenius Kabi AG, Hospira, Inc., Novartis International AG, Sun Pharmaceutical Industries Limited and Others......68
Generic Lidoderm......69
Table 64: Market Shares of Leading Generic Lidoderm Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Actavis plc, Endo International plc authorized Generic, Mylan N.V., and Other Generics......69
Generic Percocet......70
Table 65: Market Shares of Leading Generic Percocet Manufacturers in the US (2015) - Percentage Breakdown by Value for Actavis Plc, Mallinckrodt Pharmaceuticals, and Others......70
Generic Vicodin......71
Table 66: Market Shares of Leading Generic Vicodin Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis Plc, Mallinckrodt, and Others......71
Table 67: Amphastar Pharmaceuticals, Inc.'s Sales by Product (2015) - Percentage Share Breakdown by Value for Cortrosyn, Enoxaparin and Others......72